Sunshine Biopharma, Inc. (SBFM)

Sunshine Biopharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	9.69	16.29	21.83	2.05	0.99
Short-Term Investments	-	-	-	0.01	0.01
Cash & Short-Term Investments	9.69	16.29	21.83	2.05	1
Cash Growth	-40.55%	-25.36%	963.27%	105.79%	1974.15%
Accounts Receivable	3.87	2.55	1.91	0.01	0
Receivables	3.87	2.55	1.91	0.01	0
Inventory	11.28	5.73	3.29	0.11	0.02
Prepaid Expenses	1.13	0.31	0.28	0.03	0
Total Current Assets	25.97	24.89	27.31	2.2	1.03
Property, Plant & Equipment	1.48	1.01	1.15	0.01	0.02
Other Intangible Assets	3.02	1.44	0.78	-	-
Long-Term Deferred Tax Assets	0.09	-	-	-	-
Total Assets	30.56	27.35	29.24	2.2	1.05
Accounts Payable	5.54	2.59	2.8	0.04	0.06
Accrued Expenses	-	-	-	0.05	0.02
Short-Term Debt	-	-	-	-	0.14
Current Portion of Long-Term Debt	-	-	-	-	0.82
Current Portion of Leases	0.21	0.12	0.12	-	-
Current Income Taxes Payable	0.27	0.3	0.37	-	-
Other Current Liabilities	0.3	2.55	3.63	-	-
Total Current Liabilities	6.31	5.55	6.93	0.09	1.05
Long-Term Debt	-	-	-	1.9	0.95
Long-Term Leases	0.74	0.54	0.64	-	-
Long-Term Deferred Tax Liabilities	-	0.05	0.04	-	-
Total Liabilities	7.06	6.14	7.62	1.99	2
Common Stock	0	0.03	0.02	0	0
Additional Paid-In Capital	93.35	84.39	80.84	32.79	19.17
Retained Earnings	-69.04	-63.91	-59.4	-32.66	-20.22
Comprehensive Income & Other	-0.83	0.7	0.16	-0.02	-0
Total Common Equity	23.49	21.21	21.63	0.11	-1.05
Shareholders' Equity	23.5	21.21	21.63	0.21	-0.95
Total Liabilities & Equity	30.56	27.35	29.24	2.2	1.05
Total Debt	0.95	0.66	0.77	1.9	1.91
Net Cash (Debt)	8.73	15.63	21.06	0.15	-0.92
Net Cash Growth	-44.14%	-25.77%	13687.37%	-	-
Net Cash Per Share	12.45	1285.11	-	-	-
Filing Date Shares Outstanding	2.71	0.05	0.01	-	-
Total Common Shares Outstanding	2.58	0.01	0.01	-	-
Working Capital	19.65	19.34	20.38	2.1	-0.03
Book Value Per Share	9.10	1513.44	1915.04	-	-
Tangible Book Value	20.47	19.76	20.85	0.11	-1.05
Tangible Book Value Per Share	7.93	1410.37	1846.25	-	-
Machinery	-	0.54	0.48	-	0.07
Leasehold Improvements	-	0.02	-	-	-

Updated Nov 5, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q